Brickell Biotech DPO Ratio 2011-2026 | BBI

Annual DPO Ratio Brickell Biotech

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	105	68.3	18.9	24.5	7.65	11.4	-	12.5

All numbers in USD currency

Maximum	Minimum	Average
105	7.65	35.4

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Esperion Therapeutics ESPR	7.93 K	$ 3.13	0.55 %	$ 651 M	USA
Exelixis EXEL	148	$ 48.2	8.51 %	$ 13.1 B	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Fortress Biotech FBIO	400	$ 2.53	2.85 %	$ 70.6 M	USA
Galapagos NV GLPG	81.9	$ 28.81	1.48 %	$ 2.69 B	Belgium
Ionis Pharmaceuticals IONS	815	$ 77.0	2.33 %	$ 12.3 B	USA
Kamada Ltd. KMDA	106	$ 8.29	0.91 %	$ 260 M	Israel
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Kymera Therapeutics KYMR	46.6	$ 85.79	3.72 %	$ 7.25 B	USA
Ligand Pharmaceuticals Incorporated LGND	77.8	$ 231.58	-0.31 %	$ 4.24 B	USA
Liquidia Corporation LQDA	209	$ 41.64	3.75 %	$ 3.58 B	USA
ACADIA Pharmaceuticals ACAD	75.2	$ 22.58	1.03 %	$ 3.74 B	USA
MannKind Corporation MNKD	108	$ 3.61	26.17 %	$ 1.1 B	USA
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
Arcutis Biotherapeutics ARQT	133	$ 24.0	2.46 %	$ 3.05 B	USA
Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA